Literature DB >> 32043619

Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.

Paola Bianchi1, Elisa Fermo1, Kimberly Lezon-Geyda2, Eduard J van Beers3, Holmes D Morton4, Wilma Barcellini1, Bertil Glader5, Satheesh Chonat6, Yaddanapudi Ravindranath7, Peter E Newburger8, Nina Kollmar9, Jenny M Despotovic10, Madeleine Verhovsek11, Mukta Sharma12, Janet L Kwiatkowski13, Kevin H M Kuo14, Marcin W Wlodarski15, Hassan M Yaish16, Susanne Holzhauer17, Heng Wang18, Joachim Kunz19, Kathryn Addonizio20, Hasan Al-Sayegh20, Wendy B London20, Oliver Andres21, Richard van Wijk22, Patrick G Gallagher23, Rachael F F Grace21.   

Abstract

Pyruvate kinase (PK) deficiency is a rare recessive congenital hemolytic anemia caused by mutations in the PKLR gene. This study reports the molecular features of 257 patients enrolled in the PKD Natural History Study. Of the 127 different pathogenic variants detected, 84 were missense and 43 non-missense, including 20 stop-gain, 11 affecting splicing, five large deletions, four in-frame indels, and three promoter variants. Within the 177 unrelated patients, 35 were homozygous and 142 compound heterozygous (77 for two missense, 48 for one missense and one non-missense, and 17 for two non-missense variants); the two most frequent mutations were p.R510Q in 23% and p.R486W in 9% of mutated alleles. Fifty-five (21%) patients were found to have at least one previously unreported variant with 45 newly described mutations. Patients with two non-missense mutations had lower hemoglobin levels, higher numbers of lifetime transfusions, and higher rates of complications including iron overload, extramedullary hematopoiesis, and pulmonary hypertension. Rare severe complications, including lower extremity ulcerations and hepatic failure, were seen more frequently in patients with non-missense mutations or with missense mutations characterized by severe protein instability. The PKLR genotype did not correlate with the frequency of complications in utero or in the newborn period. With ICCs ranging from 0.4 to 0.61, about the same degree of clinical similarity exists within siblings as it does between siblings, in terms of hemoglobin, total bilirubin, splenectomy status, and cholecystectomy status. Pregnancy outcomes were similar across genotypes in PK deficient women. This report confirms the wide genetic heterogeneity of PK deficiency.
© 2020 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32043619      PMCID: PMC8127999          DOI: 10.1002/ajh.25753

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  33 in total

1.  Hematologically important mutations: red cell pyruvate kinase (Third update).

Authors:  P Bianchi; A Zanella
Journal:  Blood Cells Mol Dis       Date:  2000-02       Impact factor: 3.039

2.  Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management.

Authors:  Nicholas L Rider; Kevin A Strauss; Krysta Brown; Armin Finkenstedt; Erik G Puffenberger; Christine L Hendrickson; Donna L Robinson; Nikolas Muenke; Chris Tselepis; Lauren Saunders; Heinz Zoller; D Holmes Morton
Journal:  Am J Hematol       Date:  2011-08-03       Impact factor: 10.047

3.  Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population.

Authors:  E Beutler; T Gelbart
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

4.  Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency.

Authors:  Shruti Bagla; Kanta Bhambhani; Manisha Gadgeel; Steven Buck; Jian-Ping Jin; Yaddanapudi Ravindranath
Journal:  Haematologica       Date:  2019-04-04       Impact factor: 9.941

5.  The human liver-type pyruvate kinase (PKL) gene is on chromosome 1 at band q21.

Authors:  H Satoh; K Tani; M C Yoshida; M Sasaki; S Miwa; H Fujii
Journal:  Cytogenet Cell Genet       Date:  1988

6.  Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients.

Authors:  A Zanella; P Bianchi; L Baronciani; M Zappa; E Bredi; C Vercellati; F Alfinito; G Pelissero; G Sirchia
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

Review 7.  Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.

Authors:  A Zanella; P Bianchi
Journal:  Baillieres Best Pract Res Clin Haematol       Date:  2000-03

8.  Pyruvate kinase deficiency associated with severe liver dysfunction in the newborn.

Authors:  Martine F Raphaël; Richard Van Wijk; Joachim J Schweizer; Netteke A Y Schouten-van Meeteren; Angelika Kindermann; Wouter W van Solinge; Frans J Smiers
Journal:  Am J Hematol       Date:  2007-11       Impact factor: 10.047

Review 9.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

10.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

View more
  16 in total

1.  Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report.

Authors:  Sha Lin; Xintian Hua; Jinrong Li; Yifei Li
Journal:  Front Cardiovasc Med       Date:  2022-04-26

2.  Prevalence of pyruvate kinase deficiency: A systematic literature review.

Authors:  Matthew H Secrest; Mike Storm; Courtney Carrington; Deborah Casso; Keely Gilroy; Leanne Pladson; Audra N Boscoe
Journal:  Eur J Haematol       Date:  2020-06-23       Impact factor: 2.997

Review 3.  Trends in the Development of Diagnostic Tools for Red Blood Cell-Related Diseases and Anemias.

Authors:  Lars Kaestner; Paola Bianchi
Journal:  Front Physiol       Date:  2020-05-26       Impact factor: 4.566

4.  Rare anemias in adolescents.

Authors:  Joan Lluis Vives-Corrons; Elena Krishnevskaya
Journal:  Acta Biomed       Date:  2021-02-18

Review 5.  Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.

Authors:  Roberta Russo; Roberta Marra; Barbara Eleni Rosato; Achille Iolascon; Immacolata Andolfo
Journal:  Front Physiol       Date:  2020-12-22       Impact factor: 4.566

6.  Comorbidities and complications in adults with pyruvate kinase deficiency.

Authors:  Audra N Boscoe; Yan Yan; Elizabeth Hedgeman; Eduard J van Beers; Hanny Al-Samkari; Wilma Barcellini; Stefan W Eber; Bertil Glader; Hassan M Yaish; Satheesh Chonat; Mukta Sharma; Kevin H M Kuo; Ellis J Neufeld; Heng Wang; Madeleine Verhovsek; Sujit Sheth; Rachael F Grace
Journal:  Eur J Haematol       Date:  2021-01-24       Impact factor: 2.997

7.  A Proposed Concept for Defective Mitophagy Leading to Late Stage Ineffective Erythropoiesis in Pyruvate Kinase Deficiency.

Authors:  Annelies Johanna van Vuren; Eduard Johannes van Beers; Richard van Wijk
Journal:  Front Physiol       Date:  2021-01-20       Impact factor: 4.566

Review 8.  Congenital Hemolytic Anemias: Is There a Role for the Immune System?

Authors:  Anna Zaninoni; Elisa Fermo; Cristina Vercellati; Anna Paola Marcello; Wilma Barcellini; Paola Bianchi
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

9.  A Family Affected by a Life-Threatening Erythrocyte Defect Caused by Pyruvate Kinase Deficiency With Normal Iron Status: A Case Report.

Authors:  Karolina Maciak; Anna Adamowicz-Salach; Jaroslaw Poznanski; Monika Gora; Jan Fronk; Beata Burzynska
Journal:  Front Genet       Date:  2020-10-28       Impact factor: 4.599

Review 10.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.